Silverarc Capital Management, LLC Insmed Inc Transaction History

Silverarc Capital Management, LLC

$402 Million
Q3 2024

A detailed history of Silverarc Capital Management, LLC transactions in Insmed Inc stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 347,695 shares of INSM stock, worth $25.2 Million. This represents 6.32% of its overall portfolio holdings.

Number of Shares

347,695

Previous 140,000 148.35%

Holding current value

$25.2 Million

Previous $9.38 Million 170.59%

% of portfolio

6.32%

Previous 2.66%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $12.9 Million - $16.4 Million	207,695 Added 148.35%	347,695 $25.4 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $580,448 - $1.84 Million	26,384 Added 23.22%	140,000 $9.38 Million
Q1 2024 May 14, 2024	SELL	$25.72 - $29.94 $1.08 Million - $1.25 Million	-41,888 Reduced 26.94%	113,616 $3.08 Million
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $119,840 - $162,413	5,117 Added 3.4%	155,504 $4.82 Million
Q3 2023 Nov 13, 2023	BUY	$19.86 - $26.93 $117,630 - $159,506	5,923 Added 4.1%	150,387 $3.8 Million
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $11,014 - $14,137	670 Added 0.47%	144,464 $3.05 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $314,289 - $420,019	19,329 Added 15.53%	143,794 $2.45 Million
Q4 2022 Feb 14, 2023	SELL	$16.98 - $23.15 $1.69 Million - $2.3 Million	-99,551 Reduced 44.44%	124,465 $2.49 Million
Q3 2022 Oct 28, 2022	BUY	$20.88 - $28.21 $240,829 - $325,374	11,534 Added 5.43%	224,016 $4.83 Million
Q2 2022 Jul 25, 2022	BUY	$17.07 - $25.71 $1.88 Million - $2.84 Million	110,415 Added 108.18%	212,482 $4.19 Million
Q1 2022 May 13, 2022	BUY	$20.42 - $28.13 $29,527 - $40,675	1,446 Added 1.44%	102,067 $2.4 Million
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $1.92 Million - $2.47 Million	-73,967 Reduced 42.37%	100,621 $2.74 Million
Q3 2021 Nov 15, 2021	SELL	$22.46 - $29.47 $63,898 - $83,842	-2,845 Reduced 1.6%	174,588 $4.81 Million
Q2 2021 Aug 16, 2021	SELL	$24.17 - $36.01 $323,322 - $481,705	-13,377 Reduced 7.01%	177,433 $5.05 Million
Q1 2021 May 18, 2021	BUY	$32.28 - $44.3 $510,346 - $700,383	15,810 Added 9.03%	190,810 $6.5 Million
Q4 2020 Feb 16, 2021	BUY	$31.45 - $40.54 $5.5 Million - $7.09 Million	175,000 New	175,000 $5.83 Million

Others Institutions Holding INSM

# of Institutions

475

Shares Held

179M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.82B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Account

Silverarc Capital Management, LLC Insmed Inc Transaction History